정맥 조명기 : 시장 점유율 분석, 산업 동향, 통계, 성장 예측(2025-2030년)

The Vein Illuminator Market size is estimated at USD 0.3 billion in 2025, and is expected to reach USD 1.04 billion by 2030, at a CAGR of 27.80% during the forecast period (2025-2030).

Robust growth reflects health systems' focus on first-attempt venipuncture success, an outcome now tied to U.S. Medicare's value-based purchasing scores. Demand is amplified by aging and obese populations that make traditional vein palpation unreliable, while rising chronic-disease monitoring requires more frequent blood draws. Technology improvements in near-infrared (NIR) imaging, falling component costs, and portable form factors further accelerate adoption. Asia-Pacific's push to localize medical-device manufacturing and China's hospital modernization are tilting future revenue toward cost-optimized systems. Competitive pressure is intensifying as local firms introduce low-price NIR devices that undercut established brands while premium models layer on AI guidance and multi-modal imaging.

Global Vein Illuminator Market Trends and Insights

Rising First-Attempt Success Rates Drive Quality Metrics

Clinical trials in pediatric units showed first-stick success climbing to 74.1% with AccuVein AV400 compared with 40.7% using palpation, trimming procedure time from 169 seconds to 44 seconds. Health-system executives translate these gains directly into higher HCAHPS patient-experience scores, which shape Medicare reimbursements, elevating device purchases to strategic priorities. Patient surveys reveal 93% of respondents rate hospitals higher when staff employ visualization tools.

Growth in Chronic-Disease Blood Draws

More frequent HbA1c, lipid, and renal tests among diabetic and cardiovascular cohorts raise annual venipuncture volumes, stressing phlebotomy capacity. Aging vasculature and drug-induced vein fragility heighten failure risk, prompting facilities to equip labs with portable NIR finders that cut repeat sticks and consumable waste.

High Capital and Per-Unit Device Costs

Premium NIR systems list between USD 4,000 and USD 27,000, squeezing budgets of small hospitals. Experimental open-source models built from recycled optics have demonstrated comparable vein contrast for USD 25, hinting at future price erosion.

Other drivers and restraints analyzed in the detailed report include:

1. Ageing and Obese Populations Challenge Traditional Methods
2. Hospital Push for Patient-Experience KPIs
3. Lack of Reimbursement Codes

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Near-Infrared Illumination controlled 50.3% revenue in 2024, underpinning the vein illuminator market with a mature, cost-efficient platform. Ultrasound-Augmented units, posting 31.8% CAGR to 2030, carve share in difficult-access patients via deeper imaging and synergy with existing ultrasound carts. Transillumination remains a pediatric niche due to softer light, while multispectral hybrids gain research traction. Patent filings such as the dual-mode VeinCAP system illustrate convergence trends toward single devices offering NIR plus diffuse hyperspectral views. As feature sets widen, vendors differentiate on AI algorithms that auto-grade vein quality and log success metrics to electronic health records.

Hand-held and Portable devices occupied 61.2% of 2024 revenue because nurses favor pocketable tools that shift easily between wards. Wearable and Clip-On Modules, climbing at 34.1% CAGR, free clinicians' hands during complex cannulations, and feed video to smart glasses for teaching. Table-top carts persist in blood banks where mounted cameras stay calibrated for long draws. IoT connectivity is redefining design priorities: next-generation wearables integrate Wi-Fi and cloud dashboards that benchmark first-stick rates, transforming basic lights into quality-management nodes.

Vein Illuminator Market is Segmented by Technology (Near-Infrared (NIR) Illumination, Transillumination, and More), Product Type (Hand-Held and Portable, Table-Top/Cart-Mounted, and Wearable and Clip-On Modules), Application (Intravenous (IV) Access, Blood Draw/Venipuncture Assistance, and More), End-User (Hospitals and Clinics, Blood Donation Camps and Blood Banks, and More), and Geography.

Geography Analysis

North America retained 37.2% 2024 revenue leadership on the back of sophisticated infrastructure and reimbursement programs that pay for patient-experience outcomes. U.S. hospitals embed first-stick statistics into quality dashboards, ensuring repeat device orders. Canada's single-payer system favors province-wide contracts that lower per-unit costs, while Mexico's private medical-tourism clinics install finders as patient-comfort differentiators.

Europe's multi-payer environment produces steady uptake; Germany's university hospitals pilot multi-modal units, and the United Kingdom's NHS negotiates bulk pricing to support vascular-access safety goals. CE Mark harmonization smooths cross-border sales and encourages newer entrants from Scandinavia and Eastern Europe.

The vein illuminator market size in Asia-Pacific is expanding at a 33.2% CAGR, making it the global growth engine. India's Production-Linked Incentive scheme subsidizes domestic device plants, reducing import reliance. China's hospital-upgrade program requires equipment that boosts nursing efficiency; local brands undercut imports by bundling visualization with IV kits. Japan's super-aged population and high device standards favor premium dual-mode systems, while South Korea's start-ups test AI-enabled smartphone adapters for home infusion services.

1. AccuVein Inc.
2. Christie Medical Holdings Inc.
3. TransLite LLC (Veinlite)
4. VueTek Scientific LLC
5. Venoscope LLC
6. Near Infrared Imaging Inc.
7. ZD Medical Inc.
8. VeinSight (Surmount Electronic)
9. Shenzhen Vivolight Medical Device and Technology Co.
10. Veincas Medical Ltd.
11. SIFSOF LLC
12. NextVein LLC
13. Infinium Medical Inc.
14. B. Braun Medical Inc.
15. Koninklijke Philips N.V.
16. Siemens Healthineers AG
17. Baxter International Inc.
18. GE Healthcare Technologies Inc.
19. Osang Healthcare Co., Ltd.
20. Kingmaker Biomedical Inc.
21. Dhanika Instrument Co.
22. Zhongke Micro-Light Medical Equipment Co.
23. YSENMED Medical Equipment Co.
24. Xavant Medical (Pty) Ltd.
25. ALEH Medical Laser and Systems
26. FY Medical Devices Co.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising first-attempt success rates for IV and phlebotomy
  • 4.2.2 Growth in chronic-disease related blood draws
  • 4.2.3 Ageing and obese populations with difficult venous access
  • 4.2.4 Hospital push for patient-experience KPIs
  • 4.2.5 AI-integrated mobile vein-finder apps
  • 4.2.6 Adoption in cosmetic/aesthetic injections
• 4.3 Market Restraints
  • 4.3.1 High capital and per-unit device costs
  • 4.3.2 Lack of reimbursement codes
  • 4.3.3 Training gaps in low-resource settings
  • 4.3.4 Regulatory ambiguity for aesthetic-only devices
• 4.4 Industry Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry
• 4.8 Impact of Macroeconomic Factors on the Market

5 MARKET SIZE AND GROWTH FORECASTS (VALUES)

• 5.1 By Technology
  • 5.1.1 Near-Infrared (NIR) Illumination
  • 5.1.2 Transillumination
  • 5.1.3 Ultrasound-Augmented
  • 5.1.4 Multispectral/Hybrid
  • 5.1.5 Others
• 5.2 By Product Type
  • 5.2.1 Hand-held and Portable
  • 5.2.2 Table-Top/Cart-Mounted
  • 5.2.3 Wearable and Clip-On Modules
• 5.3 By Application
  • 5.3.1 Intravenous (IV) Access
  • 5.3.2 Blood Draw/Venipuncture Assistance
  • 5.3.3 Sclerotherapy and Varicose Vein Treatment
  • 5.3.4 Emergency and Critical Care
  • 5.3.5 Cosmetic/Aesthetic Injections
• 5.4 By End-user
  • 5.4.1 Hospitals and Clinics
  • 5.4.2 Blood Donation Camps and Blood Banks
  • 5.4.3 Ambulatory Surgical Centers
  • 5.4.4 Rehabilitation and Nursing Homes
  • 5.4.5 Academic and Research Institutions
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 South America
    • 5.5.2.1 Brazil
    • 5.5.2.2 Argentina
    • 5.5.2.3 Chile
    • 5.5.2.4 Rest of South America
  • 5.5.3 Europe
    • 5.5.3.1 Germany
    • 5.5.3.2 United Kingdom
    • 5.5.3.3 France
    • 5.5.3.4 Italy
    • 5.5.3.5 Spain
    • 5.5.3.6 Russia
    • 5.5.3.7 Rest of Europe
  • 5.5.4 Asia-Pacific
    • 5.5.4.1 China
    • 5.5.4.2 India
    • 5.5.4.3 Japan
    • 5.5.4.4 South Korea
    • 5.5.4.5 Malaysia
    • 5.5.4.6 Singapore
    • 5.5.4.7 Australia
    • 5.5.4.8 Rest of Asia-Pacific
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 Middle East
    • 5.5.5.1.1 United Arab Emirates
    • 5.5.5.1.2 Saudi Arabia
    • 5.5.5.1.3 Turkey
    • 5.5.5.1.4 Rest of Middle East
    • 5.5.5.2 Africa
    • 5.5.5.2.1 South Africa
    • 5.5.5.2.2 Nigeria
    • 5.5.5.2.3 Rest of Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.4.1 AccuVein Inc.
  • 6.4.2 Christie Medical Holdings Inc.
  • 6.4.3 TransLite LLC (Veinlite)
  • 6.4.4 VueTek Scientific LLC
  • 6.4.5 Venoscope LLC
  • 6.4.6 Near Infrared Imaging Inc.
  • 6.4.7 ZD Medical Inc.
  • 6.4.8 VeinSight (Surmount Electronic)
  • 6.4.9 Shenzhen Vivolight Medical Device and Technology Co.
  • 6.4.10 Veincas Medical Ltd.
  • 6.4.11 SIFSOF LLC
  • 6.4.12 NextVein LLC
  • 6.4.13 Infinium Medical Inc.
  • 6.4.14 B. Braun Medical Inc.
  • 6.4.15 Koninklijke Philips N.V.
  • 6.4.16 Siemens Healthineers AG
  • 6.4.17 Baxter International Inc.
  • 6.4.18 GE Healthcare Technologies Inc.
  • 6.4.19 Osang Healthcare Co., Ltd.
  • 6.4.20 Kingmaker Biomedical Inc.
  • 6.4.21 Dhanika Instrument Co.
  • 6.4.22 Zhongke Micro-Light Medical Equipment Co.
  • 6.4.23 YSENMED Medical Equipment Co.
  • 6.4.24 Xavant Medical (Pty) Ltd.
  • 6.4.25 ALEH Medical Laser and Systems
  • 6.4.26 FY Medical Devices Co.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

• 7.1 White-Space and Unmet-Need Assessment